Proteomics

Dataset Information

0

Engineering Linear Cap-independent mRNA Vaccines with Intrinsic 1 Adjuvanticity for Potent Cancer Immunotherapy


ABSTRACT: We present 25 a streamlined linear cap-independent RNA (LciRNA) cancer vaccine platform that achieves stable 26 expression in vivo without 5’ capping or ribonucleotide modification, and innately stimulates 27 immune responses to enhance antitumor immunity. By fusing a UPA protective sequence, composed 28 of a viral exoribonuclease-resistant RNA (xrRNA) and a poly(A) binding protein (PABP) motif, 29 with an optimized Enterovirus A internal ribosome entry site, LciRNA resists 5’ exonuclease decay 30 and drives superior in vivo expression.

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Hela Cell

SUBMITTER: Shenglin Huang  

LAB HEAD: Shenglin Huang

PROVIDER: PXD067836 | Pride | 2026-01-26

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
Control_RB1_1_40129.d.zip Other
UPA_RB1_1_40132.d.zip Other
checksum.txt Txt
peptides.pep.xml Pepxml
Items per page:
1 - 4 of 4

Similar Datasets

2012-09-01 | E-GEOD-34641 | biostudies-arrayexpress
2018-10-19 | E-MTAB-6180 | biostudies-arrayexpress
2021-12-31 | GSE187450 | GEO
2009-06-21 | GSE16358 | GEO
2025-05-07 | PXD053296 | Pride
2024-09-30 | GSE261826 | GEO
2019-11-12 | PXD010960 | Pride
| PRJDB39521 | ENA
2019-01-31 | PXD012229 | Pride
2025-05-07 | PXD055987 | Pride